Production of an emericellin and its analogues as fungal biological responses for Shimbu-to extract
Production of an emericellin and its analogues as fungal biological responses for Shimbu-to extract
复制标题
生产艾美西林及其类似物作为 Shimbu-to 提取物的真菌生物反应
DOI:
10.1007/s11418-017-1156-8
复制
发表时间:
2017
影响因子:
3.3
通讯作者:
Hosoe Tomoo
中科院分区:
文献类型:
--
作者:
Inoue Nobuhiro;Wakana Daigo;Takeda Hisashi;Yaguchi Takashi;Hosoe Tomoo
This research examined the production of fungal metabolites as a biological response to Kampo medicines. Shimbu-to (SMB) is a Kampo medicine composed of five herbal components: peony root (Shakuyaku), ginger (Shokyo), processed aconite root (Bushi),Poriasclerotium (Bukuryo), andAtractylodes lancearhizomes (Sojutsu). High-performance liquid chromatography (HPLC) analysis of the fungusAspergillus nidulansCBS 112.46 incubated in potato dextrose broth supplemented with SMB extract revealed emericellin (2) as the major peak and new xanthone analogues 24-hydroxyshamixanthone (1), shamixanthone (3), epishamixanthone (4), pre-shamixanthone (5), and variecoxanthone A (6) as minor peaks. The structure of1was determined by detailed analysis of 1D-NMR, 2D-NMR, and MS data. The results suggest that SMB extract regulates the biosynthesis of emericellin and its analogues inA. nidulans. Further investigations revealed that glucose induces the biosynthesis of emericellin and its analogues inA. nidulansin a concentration-dependent manner.